Log in
Sign up free

Home
Sectors
Earnings
IPOs
Splits

Example searches

AAPL 10-K FY2019
Visa 10-Q
shopify
renewables AND wind 8-K 6-K NOT TAC
cryptocurrency OR "blockchain technology" OR bitcoin 2018-2021

HOTH Dashboard HOTH
Financials Financials
Data Charts Data
Institutional Ownership Data Ownership
Insider Trades Insider
Short Interest Shorts
ESG ESG
All Filings Filings
8-K Filing 8-K

HOTH Hoth Therapeutics 8-K2021License Covers Novel Molecular Entity Developed by the Walter Reed Army Institute of Research

8 Jan 21

Files SEC

8-K Current report
10.1 Form of Securities Purchase Agreement
10.2 Form of Warrant
10.3 Form of Registration Rights Agreement
10.4 Form of Placement Agent Warrant
99.1 Press Release Dated January 4, 2021
99.2 Press Release Dated January 5, 2021

Content Analysis ?

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability

HOTH 8-K Filings

8 Jan 21 License Covers Novel Molecular Entity Developed by the Walter Reed Army Institute of Research
8 Dec 20 Other Events
21 Sep 20 Hoth Therapeutics Enters into Sponsored Research Agreement for On-the-go COVID-19 Testing Device
11 Sep 20 Other Events

Filing View

Default size S M L
Default font Times Arial

Search this filing

All

Tables only

Footnotes only

Pre-defined:

Table of Contents

Get all this for free

Email alerts for new filings that match keywords or companies
Plot, compare & download financial data
10-K & 10-Q redlined comparisons
Advanced filing search & analysis
Sentiment analysis for financial filings
Favorites, search history, and more…

Sign up for free now More benefits

Top HOTH

Log in
Sign up
Benefits
Help
Contact
Terms
Privacy

© 2021 Eighty-Five Technologies Inc. Not affiliated with SEC EDGAR.